Valuation: BioElectronics Corporation

Market Cap 12.35M 10.77M 10.17M 9.24M 17.3M 1.19B 17.38M 122M 47.01M 603M 46.4M 45.37M 1.94B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.41M 21.16M 19.21M 35.99M 2.47B 36.14M 253M 97.79M 1.25B 96.52M 94.38M 4.03B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+14.29%
Current month+48.15%
1 month+100.00%
3 months+14.29%
6 months+40.35%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 2019-11-14
Chairman 85 2020-06-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+14.29%+100.00%0.00% 9.88M
-1.04%+6.83%+35.84%+28.05% 241B
-0.32%+5.83%+9.58%-17.01% 149B
+2.55%+6.55%-10.35%+31.26% 139B
-0.48%+0.84%-55.70%-18.27% 62.81B
+0.01%+4.61%+18.61%+20.87% 50.87B
-1.69%-1.20%-19.89%-15.39% 48.21B
+0.08%+6.49%+23.87%+39.32% 44.11B
-1.88%+3.25%+40.14%+53.16% 41.42B
-2.27%+16.07%+133.21%+70.51% 36.18B
Average -0.50%+7.21%+27.53%+19.25% 81.24B
Weighted average by Cap. -0.26%+6.14%+15.57%+17.51%

Financials

2020 2021
Net sales 830K 723K 683K 620K 1.16M 79.6M 1.17M 8.18M 3.16M 40.47M 3.12M 3.05M 130M 1.61M 1.4M 1.33M 1.2M 2.25M 154M 2.26M 15.87M 6.13M 78.52M 6.05M 5.91M 253M
Net income -1.16M -1.01M -955K -867K -1.62M -111M -1.63M -11.44M -4.41M -56.58M -4.36M -4.26M -182M -290K -253K -239K -217K -406K -27.81M -408K -2.86M -1.1M -14.14M -1.09M -1.06M -45.49M
Net Debt 13.07M 11.4M 10.76M 9.77M 18.31M 1.25B 18.38M 129M 49.74M 638M 49.09M 48M 2.05B 13.34M 11.63M 10.99M 9.98M 18.69M 1.28B 18.77M 132M 50.78M 651M 50.12M 49.01M 2.09B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-09-18 $0.000400 0.00% 4,350,000
26-09-17 $0.000400 +14.29% 2,820,500
26-09-16 $0.000350 +6.06% 400,000
26-09-15 $0.000330 -5.71% 1,805,350
26-09-14 $0.000350 0.00% 2,842,500
  1. Stock Market
  2. Stocks
  3. BIEL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!